Our company provides regulatory and quality services for medical devices and in vitro diagnostics on a global scale. With a team of experienced professionals, we cater to the needs of medical device and IVD manufacturers, offering comprehensive regulatory consulting and quality affairs services to ensure compliance with national regulations.
Performance evaluation is a requirement in the In vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR).
It refers to an assessment and analysis of data to establish or verify the scientific validity, the analytical and, where applicable, the clinical performance of a device.
To legally market an in vitro diagnostic medical device in the EU, manufacturers must comply with the requirements outlined in the IVD Regulation. This includes providing clinical evidence that supports the intended use of the device, which should be based on an ongoing process of performance evaluation.
Performance evaluation shall demonstrate the scientific validity, analytical performance and clinical performance of the device and it shall follow a performance evaluation plan. The clinical evidence derived from the performance evaluation shall provide scientifically valid assurance that the relevant safety and performance requirements of the IVD Regulation are fulfilled.
Clinical investigations are rigorous procedures, yet they represent the most dependable means of generating comprehensive and reliable information regarding the functionality of a medical device. We offer extensive services and expertise in the careful planning, meticulous preparation, and proficient execution of clinical investigations.
We conduct multinational clinical trials for pharma, biotech, and medical device companies in EU countries. We provide fast, high-quality, and cost-effective clinical trial management services. Including: Regulatory Affairs, Regulatory Services, Project Management, Data Management and Medical Writing
Our services will be customized to meet the specific needs of your devices, resulting in a tailored proposal. Post-market activities can be provided as a single-time service or on an ongoing basis. These activities may include Post-Market Surveillance (PMS) Service, Post-Market Clinical Follow-up, and Post-Market Performance Follow-up.
Copyright © 2024 Frontiervisions - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.